A detailed history of Taylor Hoffman Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Taylor Hoffman Wealth Management holds 1,372 shares of AMGN stock, worth $362,496. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,372
Previous 1,372 -0.0%
Holding current value
$362,496
Previous $390,000 9.74%
% of portfolio
0.18%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $114,269 - $137,938
-425 Reduced 23.65%
1,372 $390,000
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $6,392 - $7,211
25 Added 1.41%
1,797 $517,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $135,474 - $165,120
600 Added 51.19%
1,772 $428,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 4.09%
1,172 $307,000
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $74,182 - $84,894
-373 Reduced 23.39%
1,222 $275,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $4,457 - $5,222
-21 Reduced 1.3%
1,595 $341,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $28,029 - $31,096
-120 Reduced 6.91%
1,616 $394,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $15,311 - $17,843
-69 Reduced 3.82%
1,736 $432,000
Q3 2020

Oct 29, 2020

SELL
$234.65 - $260.95 $17,598 - $19,571
-75 Reduced 3.99%
1,805 $459,000
Q2 2020

Aug 11, 2020

BUY
$197.81 - $242.74 $66,068 - $81,075
334 Added 21.6%
1,880 $443,000
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $62,690 - $83,144
-344 Reduced 18.2%
1,546 $313,000
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $58,152 - $69,679
334 Added 21.47%
1,890 $366,000
Q2 2019

Aug 05, 2019

SELL
$166.7 - $195.41 $55,677 - $65,266
-334 Reduced 17.67%
1,556 $287,000
Q1 2019

May 09, 2019

BUY
$180.87 - $203.88 $89,349 - $100,716
494 Added 35.39%
1,890 $359,000
Q4 2018

Jul 11, 2019

SELL
$178.4 - $208.25 $43,172 - $50,396
-242 Reduced 14.77%
1,396 $272,000
Q4 2018

Feb 01, 2019

BUY
$178.4 - $208.25 $52,449 - $61,225
294 Added 21.88%
1,638 $314,000
Q3 2018

Oct 25, 2018

BUY
$185.29 - $208.89 $39,837 - $44,911
215 Added 19.04%
1,344 $279,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $67,516 - $75,436
400 Added 54.87%
1,129 $196,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $123,047 - $137,482
729
729 $127,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Taylor Hoffman Wealth Management Portfolio

Follow Taylor Hoffman Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Hoffman Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Hoffman Wealth Management with notifications on news.